Terms: = Brain cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
13 results:
1. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
2. The interaction between
Zhang Z; Liu S
Ann Med; 2023 Dec; 55(1):1111-1122. PubMed ID: 36947060
[TBL] [Abstract] [Full Text] [Related]
3. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
[TBL] [Abstract] [Full Text] [Related]
4. Aspirin Induced Glioma Apoptosis through Noxa Upregulation.
Chang CY; Pan PH; Li JR; Ou YC; Wang JD; Liao SL; Chen WY; Wang WY; Chen CJ
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545774
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1.
Guo X; Piao H; Zhang Y; Sun P; Yao B
Bosn J Basic Med Sci; 2020 Nov; 20(4):459-470. PubMed ID: 31999936
[TBL] [Abstract] [Full Text] [Related]
6. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract] [Full Text] [Related]
7. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the Treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract] [Full Text] [Related]
8. Wnt5a Drives an Invasive Phenotype in Human Glioblastoma Stem-like Cells.
Binda E; Visioli A; Giani F; Trivieri N; Palumbo O; Restelli S; Dezi F; Mazza T; Fusilli C; Legnani F; Carella M; Di Meco F; Duggal R; Vescovi AL
Cancer Res; 2017 Feb; 77(4):996-1007. PubMed ID: 28011620
[TBL] [Abstract] [Full Text] [Related]
9. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor prognosis in Glioma Patients.
Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
[TBL] [Abstract] [Full Text] [Related]
10. Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.
Mertsch S; Schurgers LJ; Weber K; Paulus W; Senner V
BMC Cancer; 2009 Aug; 9():302. PubMed ID: 19712474
[TBL] [Abstract] [Full Text] [Related]
11. Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC.
Li XN; Shu Q; Su JM; Perlaky L; Blaney SM; Lau CC
Mol Cancer Ther; 2005 Dec; 4(12):1912-22. PubMed ID: 16373706
[TBL] [Abstract] [Full Text] [Related]
12. Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W; Gibo DM
Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
[TBL] [Abstract] [Full Text] [Related]
13. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.
Rorive S; Belot N; Decaestecker C; Lefranc F; Gordower L; Micik S; Maurage CA; Kaltner H; Ruchoux MM; Danguy A; Gabius HJ; Salmon I; Kiss R; Camby I
Glia; 2001 Mar; 33(3):241-55. PubMed ID: 11241742
[TBL] [Abstract] [Full Text] [Related]
